Endothelin-1 is a potent vasoconstrictor which is thought to be involv
ed in many human disease states. We have developed a series of indole
non-peptide endothelin antagonists which display nanomolar receptor af
finity. The representative compound from this series is PD 159433 (22)
, an ET(A) selective antagonist with an IC50 of 2 nM. The discovery, s
ynthesis and structure-activity relationships of this series of compou
nds are described. Copyright (C) 1996 Elsevier Science Ltd